thalidomide has been researched along with Erythremia in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lenalidomide is an immunomodulator used to treat 5q-myelodysplastic syndrome, myelofibrosis, and multiple myeloma." | 1.38 | Lenalidomide-induced elevated bilirubin. ( Kolesar, JM; Simondsen, KA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimoto, G | 1 |
| Miyamoto, T | 1 |
| Dasanu, CA | 1 |
| Schwartz, RA | 1 |
| Bauer, F | 1 |
| Davis, LK | 1 |
| Silver, JS | 1 |
| Reale, MA | 1 |
| Simondsen, KA | 1 |
| Kolesar, JM | 1 |
| Hebballi, S | 1 |
| Akiki, S | 1 |
| Bareford, D | 1 |
1 review available for thalidomide and Erythremia
| Article | Year |
|---|---|
[Treatment strategy for myeloproliferative neoplasms].
Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, | 2014 |
3 other studies available for thalidomide and Erythremia
| Article | Year |
|---|---|
Polycythemia vera evolving into a rapidly progressive Ph-negative del(5q)-positive myeloproliferative neoplasm refractory to lenalidomide.
Topics: Aged; Antineoplastic Agents; Chromosome Deletion; Chromosomes, Human, Pair 5; Disease Progression; D | 2011 |
Lenalidomide-induced elevated bilirubin.
Topics: Bilirubin; Humans; Lenalidomide; Male; Middle Aged; Polycythemia Vera; Primary Myelofibrosis; Thalid | 2012 |
Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.
Topics: Bone Marrow Examination; DNA Mutational Analysis; Drug Therapy, Combination; Female; Humans; Immunol | 2012 |